Khan Najat 4

What Happened Najat Khan, CEO, President and a director of Recursion Pharmaceuticals (RXRX), had 62,701 shares disposed on 2026-05-15 as shares withheld to satisfy tax withholding obligations related to a net settlement of restricted stock units. The shares were recorded at $3.04 each, for a notional value of $190,611. This was a withholding to cover taxes on RSUs rather than an open-market sale initiated by the insider.

Key Details

• Transaction date: 2026-05-15
• Shares withheld/disposed: 62,701 at $3.04 per share; total value ≈ $190,611
• Transaction code: F (payment of exercise price or tax liability / shares withheld)
• Footnote: Issuer withheld shares to satisfy its tax withholding and remittance obligations in connection with net settlement of restricted stock units (per F1)
• Filing date (Form 4): 2026-05-19
• Shares owned after transaction: Not specified in the provided filing

Context This was a routine tax-withholding/net-settlement of RSUs, commonly done by the company withholding a portion of vested shares to cover required taxes. Such transactions do not necessarily reflect the insider’s view on the company’s stock price because no open-market selling by the insider occurred.